The present invention relates generally to ambulatory infusion pumps and, more particularly, to ambulatory infusion pumps that are able to safely transition from closed loop operation to open-loop operation.
There are many applications in academic, industrial, and medical fields that benefit from devices and methods that are capable of accurately and controllably delivering fluids, such as liquids and gases that have a beneficial effect when administered in known and controlled quantities. Such devices and methods can be particularly useful in the medical field where treatments for many patients include the administration of a known amount of a substance at predetermined intervals.
One category of devices for delivering such fluids is that of pumps that have been developed for the administration of insulin and other medicaments for those suffering from both type I and type II diabetes. Some pumps configured as portable infusion devices can provide continuous subcutaneous medicament injection and/or infusion therapy for the treatment of diabetes. Such therapy may include, e.g., the regular and/or continuous injection or infusion of insulin into the skin of a person suffering from diabetes and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. Such pumps can be ambulatory/portable infusion pumps that are worn by the user and may use replaceable cartridges. Examples of such pumps and various features that can be associated with such pumps include those disclosed in U.S. Patent Publication Nos. 2013/0324928 and 2013/0053816 and U.S. Pat. Nos. 8,287,495; 8,573,027; 8,986,253; and 9,381,297, each of which is incorporated herein by reference in its entirety.
Portable infusion pumps for delivering insulin or other medicaments can be used in conjunction with blood glucose monitoring systems, such as blood glucose meters (BGMs) and continuous glucose monitoring devices (CGMs). A CGM provides a substantially continuous estimated blood glucose level through a transcutaneous sensor that estimates blood analyte levels, such as blood glucose levels, via interrogation of the patient's interstitial fluid rather than the patient's blood. CGM systems typically consist of a transcutaneously-placed sensor, a transmitter and a monitor. A CGM system allows a patient or caregiver to insert a single sensor probe under the skin for multiple days. Thus, the patient is only required to perform a single moderately invasive action with a single entry point in the subdermal layer on, e.g., a weekly basis.
Ambulatory infusion pumps typically allow the patient or caregiver to adjust the amount of insulin or other medicament delivered, by a basal rate or a bolus, based on blood glucose data obtained by a BGM or a CGM, and in some cases include the capability to automatically adjust such medicament delivery. Some ambulatory infusion pumps may include the capability to interface with a BGM or CGM such as, e.g., by receiving measured or estimated blood glucose levels and automatically adjusting or prompting the user to adjust the level of medicament being administered or planned for administration or, in cases of abnormally low blood glucose readings, automatically temporarily ceasing or prompting the user temporarily to cease insulin administration. These portable pumps may incorporate a BGM or CGM within the hardware of the pump or may communicate with a dedicated BGM or CGM via wired or wireless data communication protocols, directly and/or via a device such as a smartphone. Such pumps may be particularly important in facilitating patient compliance and improved or more accurate treatment of diabetes. One example of integration of infusion pumps with CGM devices is described in U.S. Patent Publication No. 2014/0276419, which is hereby incorporated by reference herein.
The delivery of insulin or other medicament from a portable infusion pump making use of CGM data necessitates accurate and reliable CGM data output. Some CGM devices are calibrated with blood samples to correlate actual blood glucose data with the CGM readings. However, such calibrations are only done periodically, such as every few days or hours, such as 12 hours, and the longer it has been since a calibration event the more likely the CGM is unreliable to some degree and the more unreliable the CGM is likely to become until the next calibration.
As noted above, insulin or other medicament dosing by basal rate and/or bolus techniques could automatically be provided by a pump based on readings received into the pump from a CGM device that is, e.g., external to the portable insulin pump or integrated with the pump as a pump-CGM system in a closed-loop or semi-closed-loop fashion. With respect to insulin delivery, some systems including this feature can be referred to as artificial pancreas systems because the systems serve to mimic biological functions of the pancreas for patients with diabetes.
However, there are a number of risks in automatically dosing insulin, or other medicaments, based on CGM readings that may be inaccurate or unreliable. For example, a CGM reading or readings may indicate that a user's blood glucose level is high and therefore the pump may automatically deliver a bolus of a medicament such as insulin or increase the basal rate of a medicament such as insulin to lower the user's blood glucose to a target level. If the CGM reading inaccurately indicates that the user's blood glucose level is high, the extra insulin delivered in response may actually lower the user's blood glucose level below a desired target level, possibly to a dangerously low level. This problem may not be detected until the CGM is next calibrated, perhaps not for several hours. Thus, automatically dosing medicaments such as insulin based on CGM readings can have potentially dangerous effects in situations where the CGM readings are inaccurate or unreliable relative to the user's actual blood glucose levels. Similarly, any failure of the CGM sensor, loss of signal or communication between the CGM and the pump, other mechanical or electrical failures with the system or problems with the user's operation of the system or its components, for example, may also be dangerous to the patient.
Thus, a need exists for devices and methods that maintain safe delivery of insulin to a patient in the event of a failure of closed-loop or semi-closed-loop automatic dosing of an insulin pump.
An infusion pump system providing therapy to a patient in a closed-loop or semi-closed loop mode can safely automatically revert to open-loop therapy. The system stores a default open-loop basal rate profile in memory. The system also continually tracks the insulin on board for the patient over a plurality of closed-loop therapy intervals. When an error or event occurs requiring reversion to open-loop therapy, the system automatically provides therapy according to the open-loop basal rate profile and the tracked insulin on board amount.
In one embodiment, an infusion pump system includes a pump mechanism, a memory that stores a default open-loop basal rate profile and a communications device configured to receive information from a continuous glucose monitoring system (CGM). A processor of the system causes the pump mechanism to deliver medicament to the patient in a closed-loop manner based on the information from the CGM, while continually tracking an amount of insulin on board in the patient. When an error requiring reversion from closed-loop mode to open-loop mode is detected, the processor causes the pump mechanism to deliver medicament according to the open-loop basal rate profile stored in memory and the amount of insulin on board in the patient tracked during the closed-loop mode.
In one embodiment, an infusion pump system includes a pump mechanism and a memory that stores a default open-loop basal rate profile. A processor of the system receives information from a CGM and causes the pump mechanism to automatically deliver medicament to the patient based on therapy parameters automatically determined based on the information from the CGM while continually tracking an amount of insulin on board in the patient. When an error pertaining to the CGM occurs, the pump mechanism ceases automatically delivering medicament based on the determined therapy parameters and delivers medicament according to the open-loop basal rate profile stored in memory and the tracked amount of insulin on board in the patient.
In some embodiments, the default open-loop basal rate profile is continually updated. The closed-loop therapy can be provided over a plurality of time intervals. The insulin on board can be tracked for each time interval. The open-loop basal rate profile can be updated after each time interval based on the respective tracked insulin on board amount.
The above summary is not intended to describe each illustrated embodiment or every implementation of the subject matter hereof. The figures and the detailed description that follow more particularly exemplify various embodiments.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
Such one or more other display devices may be configured to be used in place of output/display 44 or to work in connection with output/display 44 such that information may be repeated in exact or similar fashion between output/display 44 and one or more other displays, such that different information may be repeated between/among output/display 44 and one or more other display devices, or such that information is presented solely on one or more other display devices. Such one or more other display devices may also include the capability to allow a user to input information and/or commands for operation of the infusion pump, such as, e.g., via a touchscreen, microphone, keyboard or other input devices as are known in the art.
In one embodiment, the medical device can be a portable insulin pump configured to deliver insulin to a patient. Further details regarding such pump devices can be found in U.S. Pat. No. 8,287,495, which is incorporated herein by reference in its entirety. In other embodiments, the medical device can be an infusion pump configured to deliver one or more additional or other medicaments to a patient. In a further embodiment, the medical device can be a glucose meter such as a BGM or CGM. Further detail regarding such systems and definitions of related terms can be found in, e.g., U.S. Pat. Nos. 8,311,749, 7,711,402 and 7,497,827, each of which is hereby incorporated by reference herein in its entirety. In other embodiments, the medical device can monitor other physiological parameters of a patient.
Referring to
Pump 12 can interface directly or indirectly (via, e.g., a smartphone or other device) with a glucose meter, such as a blood glucose meter (BGM) or a continuous glucose monitor (CGM); the latter category of which provides a substantially continuous estimated blood glucose level through a transcutaneous sensor that estimates blood analyte levels, such as blood glucose levels, via interrogation of the patient's interstitial fluid rather than the patient's blood. Referring to
In one embodiment of a pump-CGM system, part of the CGM system 100 is incorporated into the housing of the pump 12 such that the processor 42 of the pump 12 is adapted to receive the data directly from the sensor 102 through a wired or wireless link and process and display the data on the pump display 44. In another embodiment, the CGM 100 is a separate device that communicates with the pump 12 processor 42 through a wired or wireless link to transmit processed CGM data to the pump 12 for display on the pump display 44. In further embodiments, the CGM system can transmit data to an intermediary device, such as, for example, a smartphone or dedicated remote controller that can then communicate the data to the pump.
In an embodiment of a pump-CGM system having a pump 12 that communicates with a CGM and that integrates CGM data and pump data as described herein, the CGM can automatically transmit the glucose data to the pump. The pump can then automatically determine therapy parameters and deliver medicament based on the data. For example, if the CGM data indicates that the user's blood glucose level is over a high blood glucose threshold level stored in memory, the pump can automatically calculate and deliver an insulin bolus amount and/or an increase to a user's basal rate to bring the user's blood glucose level below the threshold and/or to a target value. As with other parameters related to therapy, such thresholds and target values can be stored in memory located in the pump or, if not located in the pump, stored in a separate location and accessible by the pump processor (e.g., “cloud” storage, a smartphone, a CGM, a dedicated controller, a computer, etc., any of which is accessible via a network connection). The pump processor can periodically and/or continually execute instructions for a checking function that accesses these data in memory, compares them with data received from the CGM and acts accordingly to adjust therapy. In further embodiments, rather than the pump determining the therapy parameters, the parameters can be determined by a separate device and transmitted to the pump for execution. In such embodiments, a separate device such as the CGM or a device in communication with the CGM, such as, for example, a smartphone, dedicated controller, electronic tablet, computer, etc. can include a processor programmed to calculate therapy parameters based on the CGM data that then instruct the pump to provide therapy according to the calculated parameters.
In one embodiment, such an automatic pump-CGM system for insulin delivery is referred to as an artificial pancreas system that provides closed-loop therapy to the patient to approximate or even mimic the natural functions of a healthy pancreas. In such a system, insulin doses are calculated based on the CGM readings (that may or may not be automatically transmitted to the pump) and are automatically delivered to the patient at least in part based on the CGM reading(s). For example, if the CGM indicates that the user has a high blood glucose level or hyperglycemia, the system can automatically calculate an insulin dose necessary to reduce the user's blood glucose level below a threshold level or to a target level and automatically deliver the dose. Alternatively, the system can automatically suggest a change in therapy upon receiving the CGM data such as an increased insulin basal rate or delivery of a bolus, but can require the user to accept the suggested change prior to delivery rather than automatically delivering the therapy adjustments.
If the CGM data indicates that the user has a low blood glucose level or hypoglycemia, the system can, for example, automatically reduce a basal rate, suggest to the user to reduce a basal rate, automatically deliver or suggest that the user initiate the delivery of an amount of a substance such as, e.g., a hormone (glucagon) to raise the concentration of glucose in the blood, automatically suggest that the user, e.g., ingest carbohydrates and/or take other actions and/or make other suggestions as may be appropriate to address the hypoglycemic condition, singly or in any desired combination or sequence. Such determination can be made by the infusion pump providing therapy or by a separate device that transmits therapy parameters to the infusion pump. In some embodiments, multiple medicaments can be employed in such a system as, for example, a first medicament, e.g., insulin, that lowers blood glucose levels and a second medicament, e.g., glucagon, that raises blood glucose levels.
Because such artificial pancreas systems that incorporate CGM data automatically to adjust insulin therapy in a closed-loop fashion rely on the CGM data to be sufficiently accurate, it may be desirable to implement various features to, e.g., ensure the safety of the patient. Embodiments of the present invention therefore incorporate a temporary suspend feature for artificial pancreas and any other systems that provide closed-loop or semi-closed-loop therapy in which CGM data is relied upon, in whole or in part, automatically to determine dosing information. Semi-closed-loop therapy can include systems that provide some functions on an automatic, closed-loop basis and other functions on a manual or open-loop basis. For example, a system could automatically adjust basal delivery in a closed-loop mode as discussed above while still providing for manual administration of boluses. A system such as that described previously (that automatically suggests a change in therapy upon receiving CGM data such as an increased insulin basal rate or delivery of a bolus, but that requires the user to accept the suggested change prior to delivery rather than automatically delivering the therapy adjustments) could also be considered as providing semi-closed-loop therapy.
During operation of pump 12 in closed-loop mode, it may be desirable to revert to a conventional open-loop delivery mode under certain circumstances. Such circumstances may include, for example, a calibration error with sensor 102, a failure of sensor 102, a loss of signal between sensor 102 and glucose monitoring system 100, a loss of signal between glucose monitoring system 100 and pump 12, a failure of a user to replace a CGM sensor within the recommended expiration period (e.g., a number of days) such that the CGM sensor has lost adequate accuracy, a failure to calibrate a sensor properly, a failure to calibrate a sensor within a time interval, including a manufacturer's recommended time interval, or any other errors which may affect the accuracy of insulin delivery and/or patient safety.
In order for pump 12 safely to revert to open-loop operation mode, a basal rate profile for the patient should be known and the amount of insulin on board (JOB) in the patient at the time of transition between closed-loop and open-loop should be known. Pump 12 therefore includes a default open-loop basal rate profile 202, optionally stored within memory device 30 or optionally stored elsewhere and accessible by pump 12. In one embodiment, default open-loop basal rate profile 202 is programmed into pump 12 prior to patient use. Optionally, the open-loop basal rate profile may be updated during pump operation, such as at the conclusion of an operating interval 230 as described more fully below, to create an updated open-loop basal rate profile 203.
To determine the amount of IOB during closed-loop operation, pump 12, or other device monitoring the therapy, may continually track the amount of insulin delivered 210 over a period of time, such as an interval 230. Interval 230 may comprise a period of time such as hourly, daily, weekly, or other. In one embodiment, an amount of IOB 220 is calculated by comparing the amount of insulin delivered 210 over interval 230 to default open-loop basal rate profile 202. In another embodiment, the amount of IOB 220 is calculated by comparing the amount of insulin delivered 210 over interval 230 to an updated open-loop basal rate profile 203. In either embodiment, IOB 220 represents the difference between the amount of insulin actually delivered to the patient and a default basal rate. In various embodiments, the system can continually track IOB during closed-loop and/or open-loop operation, that is, repeatedly but with breaks/intervals in between where IOB is not tracked, or can continuously track IOB during closed-loop and/or open-loop operation, that is, constant tracking throughout system operation without interruption.
Optionally, the calculation of IOB 220 may take into account an IOB from one or more previous intervals. For example, if at the beginning of an interval 230, the patient already has a positive IOB value, that value will decrease over interval 230 according to known insulin pharmacokinetic models. The calculated decay of insulin already within the patient over interval 230 may be added to the IOB 220 determined as described above.
In embodiments utilizing updated open-loop basal rate profile 203, pump processor or other device may update profile 203 at the conclusion of an interval 230 as needed. For example, if IOB 220 is outside of a predetermined acceptable range, pump 12 may set updated open-loop basal rate profile 203 to correspond to the amount of insulin delivered 210 over the previous interval 230. In another embodiment, pump 12 may compare profile 203, amount of insulin delivered 210 and/or IOB 220 to determine and set a new updated open-loop basal rate profile 203. In some embodiments, when the actual basal insulin delivered 210 is less than the open-loop basal rate profile 203, the IOB 220 calculated during the interval 230 is not used to update the profile 203, or, alternatively, may be used as a negative contribution to reduce the open-loop basal rate profile 203.
During operation of pump 12 in closed-loop mode, upon occurrence of an event that requires reversion to open-loop mode to maintain patient safety, one of basal rate profiles 202 or 203 may be used along with IOB 220 to easily and safely transition to open-loop operation. Although primarily described herein as pump 12 processor 42 receiving CGM data, calculating therapy parameters, tracking JOB, storing and updating open-loop basal profiles, determining whether therapy should revert to open-loop, etc., in various embodiments a processor of any other device operated as a part of an infusion pump system could provide some or all of these functions. Examples of such devices include for example, a CGM, a smartphone, a dedicated remote controller, an electronic tablet, a computer, etc.
Referring now to
Referring now to
Although embodiments described herein may be discussed in the context of the controlled delivery of insulin, delivery of other medicaments, singly or in combination with one another or with insulin, including, for example, glucagon, pramlintide, etc., as well as other applications are also contemplated. Device and method embodiments discussed herein may be used for pain medication, chemotherapy, iron chelation, immunoglobulin treatment, dextrose or saline IV delivery, treatment of various conditions including, e.g., pulmonary hypertension, or any other suitable indication or application. Non-medical applications are also contemplated.
With regard to the above detailed description, like reference numerals used therein may refer to like elements that may have the same or similar dimensions, materials, and configurations. While particular forms of embodiments have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the embodiments herein. Accordingly, it is not intended that the invention be limited by the forgoing detailed description.
The entirety of each patent, patent application, publication, and document referenced herein is hereby incorporated by reference. Citation of the above patents, patent applications, publications and documents is not an admission that any of the foregoing is pertinent prior art, nor does it constitute any admission as to the contents or date of these documents.
Also incorporated herein by reference in their entirety are commonly owned U.S. Pat. Nos. 8,287,495; 8,408,421 8,448,824; 8,573,027; 8,650,937; 8,986,523; 9,173,998; 9,180,242; 9,180,243; 9,238,100; 9,242,043; 9,335,910; 9,381,297; 9,421,329; 9,486,171; 9,486,571; 9,492,608; and 9,503,526 commonly owned U.S. Patent Publication Nos. 2009/0287180; 2012/0123230; 2013/0053816; 2013/0324928; 2013/0332874; 2014/0276419; 2014/0276420; 2014/0276423; 2014/0276531; 2014/0276553; 2014/0276556 2014/0276569; 2014/0276570; 2014/0378898; 2015/0073337; 2015/0072613; 2015/0182693; 2015/0182695; 2016/0030669; 2016/0082188; and 2016/0339172 and commonly owned U.S. patent application Ser. Nos. 14/707,851; 15/241,257 and 15/354,495 and commonly owned U.S. Provisional Application Ser. Nos. 61/911,576; 61/920,902; 61/920,914; 61/920,940; 62/139,275; 62/272,255; 62/300,410; 62/352,164; 62/365,167; and 62/394,806.
Further incorporated by reference herein in their entirety are U.S. Pat. Nos. 8,601,465; 8,502,662; 8,452,953; 8,451,230; 8,449,523; 8,444,595; 8,343,092; 8,285,328; 8,126,728; 8,117,481; 8,095,123; 7,999,674; 7,819,843; 7,782,192; 7,109,878; 6,997,920; 6,979,326; 6,936,029; 6,872,200; 6,813,519; 6,641,533; 6,554,798; 6,551,276; 6,295,506; and 5,665,065.
Modifications may be made to the foregoing embodiments without departing from the basic aspects of the technology. Although the technology may have been described in substantial detail with reference to one or more specific embodiments, changes may be made to the embodiments specifically disclosed in this application, yet these modifications and improvements are within the scope and spirit of the technology. The technology illustratively described herein may suitably be practiced in the absence of any element(s) not specifically disclosed herein. The terms and expressions which have been employed are used as terms of description and not of limitation and use of such terms and expressions do not exclude any equivalents of the features shown and described or portions thereof and various modifications are possible within the scope of the technology claimed. Although the present technology has been specifically disclosed by representative embodiments and optional features, modification and variation of the concepts herein disclosed may be made, and such modifications and variations may be considered within the scope of this technology.
This application is a continuation of application Ser. No. 15/394,066 filed Dec. 29, 2016 which claims the benefit of U.S. Provisional Application No. 62/272,255 filed Dec. 29, 2015, which is hereby incorporated herein in its entirety by reference.
Number | Name | Date | Kind |
---|---|---|---|
675881 | Cassullo | Jun 1901 | A |
2462596 | Bent | Feb 1949 | A |
2629376 | Pierre et al. | Feb 1953 | A |
2691542 | Chenoweth | Oct 1954 | A |
3059639 | Blackman et al. | Oct 1962 | A |
4392849 | Petre et al. | Jul 1983 | A |
4393365 | Kondo et al. | Jul 1983 | A |
4475901 | Kraegen et al. | Oct 1984 | A |
5000664 | Lawless et al. | Mar 1991 | A |
5050612 | Matsumura | Sep 1991 | A |
5122362 | Phillips et al. | Jun 1992 | A |
5153827 | Coutre et al. | Oct 1992 | A |
5181910 | Scanlon | Jan 1993 | A |
5207666 | Idriss et al. | May 1993 | A |
5219330 | Bollish et al. | Jun 1993 | A |
5311175 | Waldman | May 1994 | A |
5338157 | Blomquist | Aug 1994 | A |
5364346 | Schrezenmeir | Nov 1994 | A |
5368562 | Blomquist et al. | Nov 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5389078 | Zalesky et al. | Feb 1995 | A |
5395326 | Haber et al. | Mar 1995 | A |
5482446 | Williamson et al. | Jan 1996 | A |
5485408 | Blomquist | Jan 1996 | A |
5551850 | Williamson et al. | Sep 1996 | A |
5558638 | Evers et al. | Sep 1996 | A |
5569186 | Lord et al. | Oct 1996 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5658252 | Johnson | Aug 1997 | A |
5665065 | Colman et al. | Sep 1997 | A |
5669877 | Blomquist | Sep 1997 | A |
5674240 | Bonutti et al. | Oct 1997 | A |
5681285 | Ford et al. | Oct 1997 | A |
5685844 | Marttila | Nov 1997 | A |
5695473 | Olsen | Dec 1997 | A |
5713856 | Eggers et al. | Feb 1998 | A |
5745378 | Barker et al. | Apr 1998 | A |
5782805 | Meinzer et al. | Jul 1998 | A |
5800420 | Gross et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5810771 | Blomquist | Sep 1998 | A |
5814015 | Gargano et al. | Sep 1998 | A |
5820622 | Gross et al. | Oct 1998 | A |
5822715 | Worthington et al. | Oct 1998 | A |
5876370 | Blomquist | Mar 1999 | A |
5879143 | Cote et al. | Mar 1999 | A |
5885211 | Eppstein et al. | Mar 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5935106 | Olsen | Aug 1999 | A |
5960403 | Brown | Sep 1999 | A |
6023629 | Tamada | Feb 2000 | A |
6024539 | Blomquist | Feb 2000 | A |
6077055 | Vilks | Jun 2000 | A |
6122536 | Sun et al. | Sep 2000 | A |
6142939 | Eppstein et al. | Nov 2000 | A |
6175752 | Say et al. | Jan 2001 | B1 |
6233471 | Berner et al. | May 2001 | B1 |
6241704 | Peterson et al. | Jun 2001 | B1 |
6248057 | Mavity et al. | Jun 2001 | B1 |
6248067 | Causey, III et al. | Jun 2001 | B1 |
6249717 | Nicholson et al. | Jun 2001 | B1 |
6255781 | Tsumura | Jul 2001 | B1 |
6272364 | Kurnik | Aug 2001 | B1 |
6298254 | Tamada | Oct 2001 | B2 |
6306420 | Cheikh | Oct 2001 | B1 |
6368272 | Porumbescu | Apr 2002 | B1 |
6379301 | Worthington et al. | Apr 2002 | B1 |
6422057 | Anderson | Jul 2002 | B1 |
6427088 | Bowman, IV et al. | Jul 2002 | B1 |
6475180 | Peterson et al. | Nov 2002 | B2 |
6505059 | Kollias et al. | Jan 2003 | B1 |
6517482 | Elden et al. | Feb 2003 | B1 |
6535714 | Melker et al. | Mar 2003 | B2 |
6539250 | Bettinger | Mar 2003 | B1 |
6544212 | Galley et al. | Apr 2003 | B2 |
6544229 | Danby et al. | Apr 2003 | B1 |
6546269 | Kurnik | Apr 2003 | B1 |
6551276 | Mann et al. | Apr 2003 | B1 |
6553244 | Lesho et al. | Apr 2003 | B2 |
6554798 | Mann et al. | Apr 2003 | B1 |
6558320 | Causey, III et al. | May 2003 | B1 |
6558351 | Steil et al. | May 2003 | B1 |
6562001 | Lebel et al. | May 2003 | B2 |
6565509 | Say et al. | May 2003 | B1 |
6571128 | Lebel et al. | May 2003 | B2 |
6577899 | Lebel et al. | Jun 2003 | B2 |
6582366 | Porumbescu | Jun 2003 | B1 |
6585644 | Lebel et al. | Jul 2003 | B2 |
6595919 | Berner et al. | Jul 2003 | B2 |
6623698 | Kuo | Sep 2003 | B2 |
6635014 | Starkweather et al. | Oct 2003 | B2 |
6641533 | Causey, III et al. | Nov 2003 | B2 |
6648821 | Lebel et al. | Nov 2003 | B2 |
6650951 | Jones et al. | Nov 2003 | B1 |
6656114 | Poulsen et al. | Dec 2003 | B1 |
6659948 | Lebel et al. | Dec 2003 | B2 |
6659978 | Kasuga et al. | Dec 2003 | B1 |
6668196 | Villegas et al. | Dec 2003 | B1 |
6687522 | Tamada | Feb 2004 | B2 |
6687546 | Lebel et al. | Feb 2004 | B2 |
6694191 | Starkweather et al. | Feb 2004 | B2 |
6733446 | Lebel et al. | May 2004 | B2 |
6740072 | Starkweather et al. | May 2004 | B2 |
6740075 | Lebel et al. | May 2004 | B2 |
6744350 | Blomquist | Jun 2004 | B2 |
6771250 | Oh | Aug 2004 | B1 |
6773412 | O'Mahony et al. | Aug 2004 | B2 |
6790198 | White et al. | Sep 2004 | B1 |
6809633 | Cern | Oct 2004 | B2 |
6809653 | Mann et al. | Oct 2004 | B1 |
6810290 | Lebel et al. | Oct 2004 | B2 |
6811533 | Lebel et al. | Nov 2004 | B2 |
6811534 | Bowman, IV et al. | Nov 2004 | B2 |
6813519 | Lebel et al. | Nov 2004 | B2 |
6827702 | Lebel et al. | Dec 2004 | B2 |
6835175 | Porumbescu | Dec 2004 | B1 |
6852104 | Blomquist | Feb 2005 | B2 |
6862466 | Ackerman | Mar 2005 | B2 |
6872200 | Mann et al. | Mar 2005 | B2 |
6873268 | Lebel et al. | Mar 2005 | B2 |
6880564 | Erickson | Apr 2005 | B2 |
6882940 | Potts et al. | Apr 2005 | B2 |
6895263 | Shin et al. | May 2005 | B2 |
6902905 | Burson et al. | Jun 2005 | B2 |
6916159 | Rush et al. | Jul 2005 | B2 |
6918542 | Silverbrook et al. | Jul 2005 | B2 |
6934220 | Cruitt et al. | Aug 2005 | B1 |
6936029 | Mann et al. | Aug 2005 | B2 |
6950708 | Bowman, IV et al. | Sep 2005 | B2 |
6957655 | Erickson et al. | Oct 2005 | B2 |
6958705 | Lebel et al. | Oct 2005 | B2 |
6966325 | Erickson | Nov 2005 | B2 |
6970742 | Mann et al. | Nov 2005 | B2 |
6974437 | Lebel et al. | Dec 2005 | B2 |
6979326 | Mann et al. | Dec 2005 | B2 |
6997920 | Mann et al. | Feb 2006 | B2 |
6998387 | Goke et al. | Feb 2006 | B1 |
6999854 | Roth | Feb 2006 | B2 |
7004928 | Aceti et al. | Feb 2006 | B2 |
7022072 | Fox et al. | Apr 2006 | B2 |
7024245 | Lebel et al. | Apr 2006 | B2 |
7025743 | Mann et al. | Apr 2006 | B2 |
7033338 | Vilks et al. | Apr 2006 | B2 |
7041082 | Blomquist et al. | May 2006 | B2 |
7073713 | Silverbrook et al. | Jul 2006 | B2 |
7083108 | Silverbrook et al. | Aug 2006 | B2 |
7092011 | Silverbrook et al. | Aug 2006 | B2 |
7097108 | Zellner et al. | Aug 2006 | B2 |
7098803 | Mann et al. | Aug 2006 | B2 |
7109878 | Mann et al. | Sep 2006 | B2 |
7150741 | Erickson et al. | Dec 2006 | B2 |
7156808 | Quy | Jan 2007 | B2 |
7179226 | Crothall et al. | Feb 2007 | B2 |
7181505 | Haller et al. | Feb 2007 | B2 |
7183068 | Burson et al. | Feb 2007 | B2 |
7187404 | Silverbrook et al. | Mar 2007 | B2 |
7201319 | Silverbrook et al. | Apr 2007 | B2 |
7204823 | Estes et al. | Apr 2007 | B2 |
7231263 | Choi | Jun 2007 | B2 |
7234645 | Silverbrook et al. | Jun 2007 | B2 |
7247702 | Gardner et al. | Jul 2007 | B2 |
7254782 | Sherer | Aug 2007 | B1 |
7267665 | Steil et al. | Sep 2007 | B2 |
7278983 | Ireland et al. | Oct 2007 | B2 |
7282029 | Poulsen et al. | Oct 2007 | B1 |
7289142 | Silverbrook | Oct 2007 | B2 |
7291107 | Hellwig et al. | Nov 2007 | B2 |
7295867 | Berner et al. | Nov 2007 | B2 |
7307245 | Faries, Jr. et al. | Dec 2007 | B2 |
7320675 | Pastore et al. | Jan 2008 | B2 |
7324012 | Mann et al. | Jan 2008 | B2 |
7341577 | Gill | Mar 2008 | B2 |
7347819 | Lebel et al. | Mar 2008 | B2 |
7347836 | Peterson et al. | Mar 2008 | B2 |
7354420 | Steil et al. | Apr 2008 | B2 |
7362971 | Silverbrook et al. | Apr 2008 | B2 |
7369635 | Spital et al. | May 2008 | B2 |
7373083 | Silverbrook et al. | May 2008 | B2 |
7377706 | Silverbrook et al. | May 2008 | B2 |
7399277 | Saidara et al. | Jul 2008 | B2 |
7402153 | Steil et al. | Jul 2008 | B2 |
7404796 | Ginsberg | Jul 2008 | B2 |
7446091 | Van Den Berghe | Nov 2008 | B2 |
7460152 | Silverbrook et al. | Dec 2008 | B2 |
7464010 | Yang et al. | Dec 2008 | B2 |
7471994 | Ford et al. | Dec 2008 | B2 |
7475825 | Silverbrook et al. | Jan 2009 | B2 |
7483050 | Silverbrook et al. | Jan 2009 | B2 |
7483743 | Mann et al. | Jan 2009 | B2 |
7491187 | Van Den Berghe et al. | Feb 2009 | B2 |
7497827 | Brister et al. | Mar 2009 | B2 |
7515060 | Blomquist | Apr 2009 | B2 |
7524045 | Silverbrook et al. | Apr 2009 | B2 |
7534226 | Mernoe et al. | May 2009 | B2 |
7547281 | Hayes et al. | Jun 2009 | B2 |
7553281 | Hellwig et al. | Jun 2009 | B2 |
7556613 | Wittmann et al. | Jul 2009 | B2 |
7559926 | Blischak | Jul 2009 | B1 |
7569030 | Lebel et al. | Aug 2009 | B2 |
7588046 | Erickson | Sep 2009 | B1 |
7591801 | Brauker et al. | Sep 2009 | B2 |
7602310 | Mann et al. | Oct 2009 | B2 |
7647237 | Malave et al. | Jan 2010 | B2 |
7651489 | Estes et al. | Jan 2010 | B2 |
7651845 | Doyle, III et al. | Jan 2010 | B2 |
7654976 | Peterson et al. | Feb 2010 | B2 |
7674485 | Bhaskaran et al. | Mar 2010 | B2 |
7676519 | McBride et al. | Mar 2010 | B2 |
7678071 | Lebel et al. | Mar 2010 | B2 |
7678762 | Green et al. | Mar 2010 | B2 |
7678763 | Green et al. | Mar 2010 | B2 |
7687272 | Buchwald et al. | Mar 2010 | B1 |
7697967 | Stafford | Apr 2010 | B2 |
7704226 | Mueller, Jr. et al. | Apr 2010 | B2 |
7708717 | Estes et al. | May 2010 | B2 |
7711402 | Shults et al. | May 2010 | B2 |
7715893 | Kamath et al. | May 2010 | B2 |
7717903 | Estes et al. | May 2010 | B2 |
7722536 | Goodnow | May 2010 | B2 |
7734323 | Blomquist et al. | Jun 2010 | B2 |
7751907 | Blomquist | Jul 2010 | B2 |
7766829 | Sloan et al. | Aug 2010 | B2 |
7766830 | Fox et al. | Aug 2010 | B2 |
7768386 | Hayter et al. | Aug 2010 | B2 |
7768408 | Reggiardo et al. | Aug 2010 | B2 |
7774145 | Brauker et al. | Aug 2010 | B2 |
7776030 | Estes et al. | Aug 2010 | B2 |
7778680 | Goode, Jr. et al. | Aug 2010 | B2 |
7785313 | Mastrototaro | Aug 2010 | B2 |
7794426 | Briones et al. | Sep 2010 | B2 |
7794427 | Estes et al. | Sep 2010 | B2 |
7794428 | Estes et al. | Sep 2010 | B2 |
7797028 | Goode, Jr. et al. | Sep 2010 | B2 |
7801582 | Peyser | Sep 2010 | B2 |
7806853 | Wittmann et al. | Oct 2010 | B2 |
7806886 | Kanderian, Jr. et al. | Oct 2010 | B2 |
7815602 | Mann et al. | Oct 2010 | B2 |
7819843 | Mann et al. | Oct 2010 | B2 |
7822455 | Hoss et al. | Oct 2010 | B2 |
7826879 | Hoss et al. | Nov 2010 | B2 |
7828528 | Estes et al. | Nov 2010 | B2 |
7831310 | Lebel et al. | Nov 2010 | B2 |
7833196 | Estes et al. | Nov 2010 | B2 |
7837647 | Estes et al. | Nov 2010 | B2 |
7837651 | Bishop et al. | Nov 2010 | B2 |
7850641 | Lebel et al. | Dec 2010 | B2 |
7860544 | Say et al. | Dec 2010 | B2 |
7869851 | Hellwig et al. | Jan 2011 | B2 |
7869853 | Say et al. | Jan 2011 | B1 |
7875022 | Wenger et al. | Jan 2011 | B2 |
7884729 | Reggiardo et al. | Feb 2011 | B2 |
7885699 | Say et al. | Feb 2011 | B2 |
7887512 | Estes et al. | Feb 2011 | B2 |
7890295 | Shin et al. | Feb 2011 | B2 |
7892199 | Mhatre et al. | Feb 2011 | B2 |
7912674 | Killoren Clark et al. | Mar 2011 | B2 |
7914450 | Goode, Jr. et al. | Mar 2011 | B2 |
7914499 | Gonnelli et al. | Mar 2011 | B2 |
7920907 | McGarraugh et al. | Apr 2011 | B2 |
7933780 | De La Huerga | Apr 2011 | B2 |
7935076 | Estes et al. | May 2011 | B2 |
7938797 | Estes | May 2011 | B2 |
7938803 | Mernoe et al. | May 2011 | B2 |
7941200 | Weinert et al. | May 2011 | B2 |
7942844 | Moberg et al. | May 2011 | B2 |
7946985 | Mastrototaro et al. | May 2011 | B2 |
7951114 | Rush et al. | May 2011 | B2 |
7959598 | Estes | Jun 2011 | B2 |
7963946 | Moubayed et al. | Jun 2011 | B2 |
7967773 | Amborn et al. | Jun 2011 | B2 |
7972296 | Braig et al. | Jul 2011 | B2 |
7976492 | Brauker et al. | Jul 2011 | B2 |
7981034 | Jennewine et al. | Jul 2011 | B2 |
7981084 | Estes et al. | Jul 2011 | B2 |
7981102 | Patel et al. | Jul 2011 | B2 |
7983745 | Hatlestad et al. | Jul 2011 | B2 |
7983759 | Stahmann et al. | Jul 2011 | B2 |
7985330 | Wang et al. | Jul 2011 | B2 |
7988630 | Osorio et al. | Aug 2011 | B1 |
7988849 | Biewer et al. | Aug 2011 | B2 |
7996158 | Hayter et al. | Aug 2011 | B2 |
8005524 | Brauker et al. | Aug 2011 | B2 |
8012119 | Estes et al. | Sep 2011 | B2 |
8016783 | Pastore et al. | Sep 2011 | B2 |
8025634 | Moubayed et al. | Sep 2011 | B1 |
8029459 | Rush et al. | Oct 2011 | B2 |
8029460 | Rush et al. | Oct 2011 | B2 |
8062249 | Wilinska et al. | Nov 2011 | B2 |
8066665 | Rush et al. | Nov 2011 | B2 |
8075527 | Rush et al. | Dec 2011 | B2 |
8079983 | Rush et al. | Dec 2011 | B2 |
8079984 | Rush et al. | Dec 2011 | B2 |
8083718 | Rush et al. | Dec 2011 | B2 |
8088098 | Yodfat et al. | Jan 2012 | B2 |
8093212 | Gardner et al. | Jan 2012 | B2 |
8105268 | Lebel et al. | Jan 2012 | B2 |
8105279 | Mernoe et al. | Jan 2012 | B2 |
8109921 | Estes et al. | Feb 2012 | B2 |
8114350 | Silver et al. | Feb 2012 | B1 |
8118770 | Galley et al. | Feb 2012 | B2 |
8119593 | Richardson et al. | Feb 2012 | B2 |
8127046 | Grant et al. | Feb 2012 | B2 |
8129429 | Sporn et al. | Mar 2012 | B2 |
8133197 | Blomquist et al. | Mar 2012 | B2 |
8140275 | Campbell et al. | Mar 2012 | B2 |
8140312 | Hayter et al. | Mar 2012 | B2 |
8147446 | Yodfat et al. | Apr 2012 | B2 |
8152789 | Starkweather et al. | Apr 2012 | B2 |
8170721 | Nickerson | May 2012 | B2 |
8177716 | Say et al. | May 2012 | B2 |
8182445 | Moubayed et al. | May 2012 | B2 |
8192394 | Estes et al. | Jun 2012 | B2 |
8192395 | Estes et al. | Jun 2012 | B2 |
8202267 | Field et al. | Jun 2012 | B2 |
8204729 | Sher | Jun 2012 | B2 |
8206296 | Jennewine | Jun 2012 | B2 |
8206350 | Mann et al. | Jun 2012 | B2 |
8208984 | Blomquist et al. | Jun 2012 | B2 |
8211062 | Estes et al. | Jul 2012 | B2 |
8219222 | Blomquist | Jul 2012 | B2 |
8221345 | Blomquist | Jul 2012 | B2 |
8221385 | Estes | Jul 2012 | B2 |
8226558 | Say et al. | Jul 2012 | B2 |
8226891 | Sloan et al. | Jul 2012 | B2 |
8231562 | Buck et al. | Jul 2012 | B2 |
8234126 | Estes | Jul 2012 | B1 |
8234128 | Martucci et al. | Jul 2012 | B2 |
8237715 | Buck et al. | Aug 2012 | B2 |
8246540 | Ginsberg | Aug 2012 | B2 |
8250483 | Blomquist | Aug 2012 | B2 |
8251904 | Zivitz et al. | Aug 2012 | B2 |
8251906 | Brauker et al. | Aug 2012 | B2 |
8257259 | Brauker et al. | Sep 2012 | B2 |
8257300 | Budiman et al. | Sep 2012 | B2 |
8260630 | Brown | Sep 2012 | B2 |
8262617 | Aeschlimann et al. | Sep 2012 | B2 |
8277435 | Estes | Oct 2012 | B2 |
8282601 | Mernoe et al. | Oct 2012 | B2 |
8287454 | Wolpert et al. | Oct 2012 | B2 |
8287495 | Michaud et al. | Oct 2012 | B2 |
8287514 | Miller et al. | Oct 2012 | B2 |
8290562 | Goode, Jr. et al. | Oct 2012 | B2 |
8298184 | DiPerna et al. | Oct 2012 | B2 |
8311749 | Brauker et al. | Nov 2012 | B2 |
8323188 | Tran | Dec 2012 | B2 |
8328754 | Estes et al. | Dec 2012 | B2 |
8343092 | Rush et al. | Jan 2013 | B2 |
8344847 | Moberg et al. | Jan 2013 | B2 |
8346399 | Blomquist | Jan 2013 | B2 |
8348885 | Moberg et al. | Jan 2013 | B2 |
8348886 | Kanderian, Jr. et al. | Jan 2013 | B2 |
8348923 | Kanderian, Jr. et al. | Jan 2013 | B2 |
8349319 | Schuchman et al. | Jan 2013 | B2 |
8357091 | Say et al. | Jan 2013 | B2 |
8369919 | Kamath | Feb 2013 | B2 |
8372040 | Huang et al. | Feb 2013 | B2 |
8376943 | Kovach et al. | Feb 2013 | B2 |
8377031 | Hayter et al. | Feb 2013 | B2 |
8380273 | Say et al. | Feb 2013 | B2 |
8409131 | Say et al. | Apr 2013 | B2 |
8414523 | Blomquist et al. | Apr 2013 | B2 |
8444595 | Brukalo et al. | May 2013 | B2 |
8449523 | Brukalo et al. | May 2013 | B2 |
8451230 | Celentano et al. | May 2013 | B2 |
8452953 | Buck et al. | May 2013 | B2 |
8454510 | Yodfat et al. | Jun 2013 | B2 |
8454575 | Estes et al. | Jun 2013 | B2 |
8454576 | Mastrototaro et al. | Jun 2013 | B2 |
8454581 | Estes et al. | Jun 2013 | B2 |
8460231 | Brauker et al. | Jun 2013 | B2 |
8465460 | Yodfat et al. | Jun 2013 | B2 |
8467980 | Campbell et al. | Jun 2013 | B2 |
8475409 | Javitt | Jul 2013 | B2 |
8486005 | Yodfat et al. | Jul 2013 | B2 |
8552880 | Kopp et al. | Oct 2013 | B2 |
8562558 | Kamath et al. | Oct 2013 | B2 |
8573027 | Rosinko et al. | Nov 2013 | B2 |
8579853 | Reggiardo et al. | Nov 2013 | B2 |
8650937 | Brown | Feb 2014 | B2 |
8657779 | Blomquist | Feb 2014 | B2 |
8712748 | Thukral et al. | Apr 2014 | B2 |
8718949 | Blomquist et al. | May 2014 | B2 |
8726266 | Kiaie et al. | May 2014 | B2 |
8775877 | McVey et al. | Jul 2014 | B2 |
8801657 | Blomquist et al. | Aug 2014 | B2 |
8882701 | DeBelser et al. | Nov 2014 | B2 |
8938306 | Lebel et al. | Jan 2015 | B2 |
8986253 | DiPerna | Mar 2015 | B2 |
8992475 | Mann et al. | Mar 2015 | B2 |
9008803 | Blomquist | Apr 2015 | B2 |
9037254 | John | May 2015 | B2 |
9089305 | Hovorka | Jul 2015 | B2 |
9364679 | John | Jun 2016 | B2 |
9381297 | Brown et al. | Jul 2016 | B2 |
9474856 | Blomquist | Oct 2016 | B2 |
9486171 | Saint | Nov 2016 | B2 |
9486578 | Finan et al. | Nov 2016 | B2 |
9669160 | Harris et al. | Jun 2017 | B2 |
9833177 | Blomquist | Dec 2017 | B2 |
9867937 | Saint et al. | Jan 2018 | B2 |
9867953 | Rosinko | Jun 2018 | B2 |
10016561 | Saint et al. | Jul 2018 | B2 |
10052049 | Blomquist et al. | Aug 2018 | B2 |
10130766 | Bibian | Nov 2018 | B1 |
10213547 | Rosinko | Feb 2019 | B2 |
10357606 | Blomquist et al. | Jul 2019 | B2 |
10357607 | Blomquist et al. | Jul 2019 | B2 |
10549051 | Rosinko | Feb 2020 | B2 |
10569016 | Rosinko | Feb 2020 | B2 |
10864322 | Saint et al. | Dec 2020 | B2 |
20010001144 | Kapp | May 2001 | A1 |
20010031944 | Peterson et al. | Oct 2001 | A1 |
20010037217 | Abensour et al. | Nov 2001 | A1 |
20010041831 | Starkweather et al. | Nov 2001 | A1 |
20020002326 | Causey, III et al. | Jan 2002 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020065454 | Lebel et al. | May 2002 | A1 |
20020072932 | Swamy | Jun 2002 | A1 |
20020077852 | Ford et al. | Jun 2002 | A1 |
20020107476 | Mann et al. | Aug 2002 | A1 |
20020143580 | Bristol et al. | Oct 2002 | A1 |
20020183693 | Peterson et al. | Dec 2002 | A1 |
20020193679 | Malave et al. | Dec 2002 | A1 |
20030032867 | Crothall et al. | Feb 2003 | A1 |
20030036683 | Kehr et al. | Feb 2003 | A1 |
20030050621 | Lebel et al. | Mar 2003 | A1 |
20030060765 | Campbell et al. | Mar 2003 | A1 |
20030065308 | Lebel et al. | Apr 2003 | A1 |
20030088238 | Poulsen et al. | May 2003 | A1 |
20030104982 | Wittmann et al. | Jun 2003 | A1 |
20030114836 | Estes et al. | Jun 2003 | A1 |
20030130616 | Steil et al. | Jul 2003 | A1 |
20030145854 | Hickle | Aug 2003 | A1 |
20030159945 | Miyazaki et al. | Aug 2003 | A1 |
20030160683 | Blomquist | Aug 2003 | A1 |
20030161744 | Vilks et al. | Aug 2003 | A1 |
20030163088 | Blomquist | Aug 2003 | A1 |
20030163090 | Blomquist et al. | Aug 2003 | A1 |
20030163223 | Blomquist | Aug 2003 | A1 |
20030163789 | Blomquist | Aug 2003 | A1 |
20030199854 | Kovach et al. | Oct 2003 | A1 |
20030208113 | Mault et al. | Nov 2003 | A1 |
20030212364 | Mann et al. | Nov 2003 | A1 |
20030212379 | Bylund et al. | Nov 2003 | A1 |
20030236489 | Jacobson et al. | Dec 2003 | A1 |
20040015102 | Cummings et al. | Jan 2004 | A1 |
20040015132 | Brown | Jan 2004 | A1 |
20040054263 | Moerman et al. | Mar 2004 | A1 |
20040068230 | Estes et al. | Apr 2004 | A1 |
20040073095 | Causey, III et al. | Apr 2004 | A1 |
20040115067 | Rush et al. | Jun 2004 | A1 |
20040122353 | Shahmirian et al. | Jun 2004 | A1 |
20040152622 | Keith et al. | Aug 2004 | A1 |
20040167464 | Ireland et al. | Aug 2004 | A1 |
20040180810 | Pilarski | Sep 2004 | A1 |
20040193025 | Steil et al. | Sep 2004 | A1 |
20040193090 | Lebel et al. | Sep 2004 | A1 |
20040225252 | Gillespie et al. | Nov 2004 | A1 |
20040254434 | Goodnow et al. | Dec 2004 | A1 |
20050021006 | Tonnies | Jan 2005 | A1 |
20050022274 | Campbell et al. | Jan 2005 | A1 |
20050027182 | Siddiqui et al. | Feb 2005 | A1 |
20050030164 | Blomquist | Feb 2005 | A1 |
20050049179 | Davidson et al. | Mar 2005 | A1 |
20050050621 | Thomas | Mar 2005 | A1 |
20050065464 | Talbot et al. | Mar 2005 | A1 |
20050065760 | Murtfeldt et al. | Mar 2005 | A1 |
20050081847 | Lee et al. | Apr 2005 | A1 |
20050095063 | Fathallah et al. | May 2005 | A1 |
20050137530 | Campbell et al. | Jun 2005 | A1 |
20050143864 | Blomquist | Jun 2005 | A1 |
20050171513 | Mann et al. | Aug 2005 | A1 |
20050182358 | Veit et al. | Aug 2005 | A1 |
20050192557 | Brauker et al. | Sep 2005 | A1 |
20050197553 | Cooper | Sep 2005 | A1 |
20050197621 | Poulsen et al. | Sep 2005 | A1 |
20050203349 | Nanikashvili | Sep 2005 | A1 |
20050203360 | Brauker et al. | Sep 2005 | A1 |
20050228234 | Yang | Oct 2005 | A1 |
20050272640 | Doyle, III et al. | Dec 2005 | A1 |
20050277872 | Colby, Jr. et al. | Dec 2005 | A1 |
20050277912 | John | Dec 2005 | A1 |
20060001538 | Kraft et al. | Jan 2006 | A1 |
20060001550 | Mann et al. | Jan 2006 | A1 |
20060014670 | Green et al. | Jan 2006 | A1 |
20060031094 | Cohen et al. | Feb 2006 | A1 |
20060047192 | Hellwig et al. | Mar 2006 | A1 |
20060047538 | Condurso et al. | Mar 2006 | A1 |
20060080059 | Stupp et al. | Apr 2006 | A1 |
20060085223 | Anderson et al. | Apr 2006 | A1 |
20060093785 | Hickle | May 2006 | A1 |
20060094985 | Aceti et al. | May 2006 | A1 |
20060122577 | Poulsen et al. | Jun 2006 | A1 |
20060132292 | Blomquist | Jun 2006 | A1 |
20060137695 | Hellwig et al. | Jun 2006 | A1 |
20060167345 | Vespasiani | Jul 2006 | A1 |
20060173406 | Hayes et al. | Aug 2006 | A1 |
20060173444 | Choy et al. | Aug 2006 | A1 |
20060202859 | Mastrototaro et al. | Sep 2006 | A1 |
20060224109 | Steil et al. | Oct 2006 | A1 |
20060253097 | Braig et al. | Nov 2006 | A1 |
20060253296 | Liisberg et al. | Nov 2006 | A1 |
20060264895 | Flanders | Nov 2006 | A1 |
20060271020 | Huang et al. | Nov 2006 | A1 |
20060272652 | Stocker et al. | Dec 2006 | A1 |
20060276771 | Galley et al. | Dec 2006 | A1 |
20070016127 | Staib et al. | Jan 2007 | A1 |
20070016170 | Kovelman | Jan 2007 | A1 |
20070016449 | Cohen et al. | Jan 2007 | A1 |
20070021733 | Hansen et al. | Jan 2007 | A1 |
20070033074 | Nitzan et al. | Feb 2007 | A1 |
20070060796 | Kim | Mar 2007 | A1 |
20070060871 | Istoc et al. | Mar 2007 | A1 |
20070060874 | Nesbitt et al. | Mar 2007 | A1 |
20070066956 | Finkel | Mar 2007 | A1 |
20070073236 | Mernoe et al. | Mar 2007 | A1 |
20070083152 | Williams, Jr. et al. | Apr 2007 | A1 |
20070083335 | Moerman | Apr 2007 | A1 |
20070093786 | Goldsmith et al. | Apr 2007 | A1 |
20070100222 | Mastrototaro et al. | May 2007 | A1 |
20070106135 | Sloan et al. | May 2007 | A1 |
20070112298 | Mueller, Jr. et al. | May 2007 | A1 |
20070112299 | Smit et al. | May 2007 | A1 |
20070118405 | Campbell et al. | May 2007 | A1 |
20070124002 | Estes et al. | May 2007 | A1 |
20070149861 | Crothall et al. | Jun 2007 | A1 |
20070156033 | Causey, III et al. | Jul 2007 | A1 |
20070156092 | Estes et al. | Jul 2007 | A1 |
20070156457 | Brown | Jul 2007 | A1 |
20070167905 | Estes et al. | Jul 2007 | A1 |
20070167912 | Causey et al. | Jul 2007 | A1 |
20070173712 | Shah et al. | Jul 2007 | A1 |
20070173762 | Estes et al. | Jul 2007 | A1 |
20070179355 | Rosen | Aug 2007 | A1 |
20070179444 | Causey et al. | Aug 2007 | A1 |
20070203454 | Shermer et al. | Aug 2007 | A1 |
20070213657 | Jennewine et al. | Sep 2007 | A1 |
20070233051 | Hohl et al. | Oct 2007 | A1 |
20070245258 | Ginggen et al. | Oct 2007 | A1 |
20070251835 | Mehta et al. | Nov 2007 | A1 |
20070253021 | Mehta et al. | Nov 2007 | A1 |
20070253380 | Jollota et al. | Nov 2007 | A1 |
20070254593 | Jollota et al. | Nov 2007 | A1 |
20070255116 | Mehta et al. | Nov 2007 | A1 |
20070255125 | Moberg et al. | Nov 2007 | A1 |
20070255126 | Moberg et al. | Nov 2007 | A1 |
20070255250 | Moberg et al. | Nov 2007 | A1 |
20070255348 | Holtzclaw | Nov 2007 | A1 |
20070258395 | Jollota et al. | Nov 2007 | A1 |
20070287985 | Estes et al. | Dec 2007 | A1 |
20070299389 | Halbert et al. | Dec 2007 | A1 |
20080004601 | Jennewine et al. | Jan 2008 | A1 |
20080030369 | Mann et al. | Feb 2008 | A1 |
20080033357 | Mann et al. | Feb 2008 | A1 |
20080033360 | Evans et al. | Feb 2008 | A1 |
20080033361 | Evans et al. | Feb 2008 | A1 |
20080045902 | Estes et al. | Feb 2008 | A1 |
20080045903 | Estes et al. | Feb 2008 | A1 |
20080045904 | Estes et al. | Feb 2008 | A1 |
20080045931 | Estes et al. | Feb 2008 | A1 |
20080051709 | Mounce et al. | Feb 2008 | A1 |
20080051714 | Moberg et al. | Feb 2008 | A1 |
20080051716 | Stutz | Feb 2008 | A1 |
20080058773 | John | Mar 2008 | A1 |
20080065007 | Peterson et al. | Mar 2008 | A1 |
20080065016 | Peterson et al. | Mar 2008 | A1 |
20080071209 | Moubayed et al. | Mar 2008 | A1 |
20080071210 | Moubayed et al. | Mar 2008 | A1 |
20080071217 | Moubayed et al. | Mar 2008 | A1 |
20080071251 | Moubayed et al. | Mar 2008 | A1 |
20080071580 | Marcus et al. | Mar 2008 | A1 |
20080076969 | Kraft et al. | Mar 2008 | A1 |
20080097289 | Steil et al. | Apr 2008 | A1 |
20080106431 | Blomquist | May 2008 | A1 |
20080114299 | Damgaard-Sorensen et al. | May 2008 | A1 |
20080132844 | Peterson et al. | Jun 2008 | A1 |
20080139907 | Rao et al. | Jun 2008 | A1 |
20080147004 | Mann et al. | Jun 2008 | A1 |
20080147041 | Kristensen | Jun 2008 | A1 |
20080147050 | Mann et al. | Jun 2008 | A1 |
20080154513 | Kovatchev et al. | Jun 2008 | A1 |
20080171697 | Jacotot et al. | Jul 2008 | A1 |
20080171967 | Blomquist et al. | Jul 2008 | A1 |
20080172026 | Blomquist | Jul 2008 | A1 |
20080172027 | Blomquist | Jul 2008 | A1 |
20080172028 | Blomquist | Jul 2008 | A1 |
20080172029 | Blomquist | Jul 2008 | A1 |
20080172030 | Blomquist | Jul 2008 | A1 |
20080172031 | Blomquist | Jul 2008 | A1 |
20080177165 | Blomquist et al. | Jul 2008 | A1 |
20080183060 | Steil et al. | Jul 2008 | A1 |
20080206799 | Blomquist | Aug 2008 | A1 |
20080228056 | Blomquist et al. | Sep 2008 | A1 |
20080249470 | Malave et al. | Oct 2008 | A1 |
20080255438 | Saidara et al. | Oct 2008 | A1 |
20080255517 | Nair et al. | Oct 2008 | A1 |
20080264024 | Baaken | Oct 2008 | A1 |
20080269585 | Ginsberg | Oct 2008 | A1 |
20080269714 | Mastrototaro et al. | Oct 2008 | A1 |
20080269723 | Mastrototaro et al. | Oct 2008 | A1 |
20080287922 | Panduro | Nov 2008 | A1 |
20080288115 | Rusnak et al. | Nov 2008 | A1 |
20080294024 | Cosentino et al. | Nov 2008 | A1 |
20080294094 | Mhatre et al. | Nov 2008 | A1 |
20080294108 | Briones et al. | Nov 2008 | A1 |
20080294109 | Estes et al. | Nov 2008 | A1 |
20080294142 | Patel et al. | Nov 2008 | A1 |
20080294294 | Blomquist | Nov 2008 | A1 |
20080300534 | Blomquist | Dec 2008 | A1 |
20080300572 | Rankers et al. | Dec 2008 | A1 |
20080300651 | Gerber et al. | Dec 2008 | A1 |
20080306434 | Dobbles et al. | Dec 2008 | A1 |
20080306444 | Brister et al. | Dec 2008 | A1 |
20080312584 | Montgomery et al. | Dec 2008 | A1 |
20080312585 | Brukalo et al. | Dec 2008 | A1 |
20090005726 | Jones et al. | Jan 2009 | A1 |
20090018779 | Cohen et al. | Jan 2009 | A1 |
20090030733 | Cohen et al. | Jan 2009 | A1 |
20090036753 | King | Feb 2009 | A1 |
20090054475 | Chen et al. | Feb 2009 | A1 |
20090067989 | Estes et al. | Mar 2009 | A1 |
20090069745 | Estes et al. | Mar 2009 | A1 |
20090069749 | Miller et al. | Mar 2009 | A1 |
20090069787 | Estes et al. | Mar 2009 | A1 |
20090085768 | Patel et al. | Apr 2009 | A1 |
20090088731 | Campbell et al. | Apr 2009 | A1 |
20090093756 | Minaie et al. | Apr 2009 | A1 |
20090105636 | Hayter et al. | Apr 2009 | A1 |
20090105646 | Hendrixson et al. | Apr 2009 | A1 |
20090112626 | Talbot et al. | Apr 2009 | A1 |
20090118592 | Klitgaard | May 2009 | A1 |
20090131860 | Nielsen | May 2009 | A1 |
20090131861 | Braig et al. | May 2009 | A1 |
20090143661 | Taub et al. | Jun 2009 | A1 |
20090150186 | Cohen et al. | Jun 2009 | A1 |
20090150865 | Young et al. | Jun 2009 | A1 |
20090156990 | Wenger et al. | Jun 2009 | A1 |
20090157003 | Jones et al. | Jun 2009 | A1 |
20090163855 | Shin et al. | Jun 2009 | A1 |
20090171269 | Jennewine et al. | Jul 2009 | A1 |
20090177142 | Blomquist et al. | Jul 2009 | A1 |
20090177147 | Blomquist et al. | Jul 2009 | A1 |
20090177154 | Blomquist | Jul 2009 | A1 |
20090177180 | Rubalcaba, Jr. et al. | Jul 2009 | A1 |
20090192366 | Mensinger et al. | Jul 2009 | A1 |
20090192724 | Brauker et al. | Jul 2009 | A1 |
20090192745 | Kamath et al. | Jul 2009 | A1 |
20090212966 | Panduro | Aug 2009 | A1 |
20090216100 | Ebner et al. | Aug 2009 | A1 |
20090240193 | Mensinger et al. | Sep 2009 | A1 |
20090247931 | Damgaard-Sorensen | Oct 2009 | A1 |
20090247982 | Krulevitch et al. | Oct 2009 | A1 |
20090254037 | Bryant, Jr. et al. | Oct 2009 | A1 |
20090267774 | Enegren et al. | Oct 2009 | A1 |
20090267775 | Enegren et al. | Oct 2009 | A1 |
20090270705 | Enegren et al. | Oct 2009 | A1 |
20090270810 | DeBelser et al. | Oct 2009 | A1 |
20090275886 | Blomquist et al. | Nov 2009 | A1 |
20090275887 | Estes | Nov 2009 | A1 |
20090281393 | Smith | Nov 2009 | A1 |
20100008795 | DiPerna | Jan 2010 | A1 |
20100010330 | Rankers et al. | Jan 2010 | A1 |
20100030045 | Gottlieb et al. | Feb 2010 | A1 |
20100030387 | Sen | Feb 2010 | A1 |
20100049164 | Estes | Feb 2010 | A1 |
20100056993 | Chase | Mar 2010 | A1 |
20100057040 | Hayter | Mar 2010 | A1 |
20100057043 | Kovatchev et al. | Mar 2010 | A1 |
20100064257 | Buck et al. | Mar 2010 | A1 |
20100069730 | Bergstrom et al. | Mar 2010 | A1 |
20100081993 | O'Connor | Apr 2010 | A1 |
20100094110 | Heller et al. | Apr 2010 | A1 |
20100094251 | Estes | Apr 2010 | A1 |
20100095229 | Dixon et al. | Apr 2010 | A1 |
20100105999 | Dixon et al. | Apr 2010 | A1 |
20100114015 | Kanderian, Jr. et al. | May 2010 | A1 |
20100121169 | Petisce et al. | May 2010 | A1 |
20100121170 | Rule | May 2010 | A1 |
20100125241 | Prud'Homme et al. | May 2010 | A1 |
20100130933 | Holland et al. | May 2010 | A1 |
20100138197 | Sher | Jun 2010 | A1 |
20100145276 | Yodfat et al. | Jun 2010 | A1 |
20100145303 | Yodfat et al. | Jun 2010 | A1 |
20100156633 | Buck, Jr. et al. | Jun 2010 | A1 |
20100160740 | Cohen et al. | Jun 2010 | A1 |
20100161236 | Cohen et al. | Jun 2010 | A1 |
20100161346 | Getschmann et al. | Jun 2010 | A1 |
20100162786 | Keenan et al. | Jul 2010 | A1 |
20100174228 | Buckingham et al. | Jul 2010 | A1 |
20100174266 | Estes | Jul 2010 | A1 |
20100174553 | Kaufman et al. | Jul 2010 | A1 |
20100179402 | Goode, Jr. et al. | Jul 2010 | A1 |
20100185142 | Kamen et al. | Jul 2010 | A1 |
20100185152 | Larsen et al. | Jul 2010 | A1 |
20100185175 | Kamen et al. | Jul 2010 | A1 |
20100192686 | Kamen et al. | Aug 2010 | A1 |
20100198034 | Thomas et al. | Aug 2010 | A1 |
20100198142 | Sloan et al. | Aug 2010 | A1 |
20100205001 | Knudsen et al. | Aug 2010 | A1 |
20100218132 | Soni et al. | Aug 2010 | A1 |
20100222765 | Blomquist et al. | Sep 2010 | A1 |
20100228186 | Estes et al. | Sep 2010 | A1 |
20100234709 | Say et al. | Sep 2010 | A1 |
20100235439 | Goodnow | Sep 2010 | A1 |
20100249530 | Rankers et al. | Sep 2010 | A1 |
20100249561 | Patek et al. | Sep 2010 | A1 |
20100261987 | Kamath et al. | Oct 2010 | A1 |
20100262078 | Blomquist | Oct 2010 | A1 |
20100262117 | Magni et al. | Oct 2010 | A1 |
20100262434 | Shaya | Oct 2010 | A1 |
20100274218 | Yodfat et al. | Oct 2010 | A1 |
20100274592 | Nitzan et al. | Oct 2010 | A1 |
20100274751 | Blomquist | Oct 2010 | A1 |
20100277119 | Montague et al. | Nov 2010 | A1 |
20100280329 | Randloev et al. | Nov 2010 | A1 |
20100286563 | Bryer et al. | Nov 2010 | A1 |
20100286601 | Yodfat et al. | Nov 2010 | A1 |
20100286653 | Kubel et al. | Nov 2010 | A1 |
20100292634 | Kircher, Jr. et al. | Nov 2010 | A1 |
20100295686 | Sloan et al. | Nov 2010 | A1 |
20100298681 | Say et al. | Nov 2010 | A1 |
20100298685 | Hayter et al. | Nov 2010 | A1 |
20100305421 | Ow-Wing | Dec 2010 | A1 |
20100305545 | Kanderian, Jr. et al. | Dec 2010 | A1 |
20100305965 | Benjamin et al. | Dec 2010 | A1 |
20100312085 | Andrews et al. | Dec 2010 | A1 |
20100324382 | Cantwell et al. | Dec 2010 | A1 |
20100324398 | Tzyy-Ping | Dec 2010 | A1 |
20100331651 | Groll | Dec 2010 | A1 |
20110004188 | Shekalim | Jan 2011 | A1 |
20110006876 | Moberg et al. | Jan 2011 | A1 |
20110009725 | Hill et al. | Jan 2011 | A1 |
20110009813 | Rankers | Jan 2011 | A1 |
20110015509 | Peyser | Jan 2011 | A1 |
20110021898 | Wei et al. | Jan 2011 | A1 |
20110022025 | Savoie et al. | Jan 2011 | A1 |
20110033833 | Blomquist et al. | Feb 2011 | A1 |
20110040247 | Mandro et al. | Feb 2011 | A1 |
20110040251 | Blomquist et al. | Feb 2011 | A1 |
20110047499 | Mandro et al. | Feb 2011 | A1 |
20110050428 | Istoc | Mar 2011 | A1 |
20110053121 | Heaton | Mar 2011 | A1 |
20110054390 | Searle et al. | Mar 2011 | A1 |
20110054391 | Ward et al. | Mar 2011 | A1 |
20110056264 | Kaplan et al. | Mar 2011 | A1 |
20110058485 | Sloan | Mar 2011 | A1 |
20110060281 | Aeschlimann et al. | Mar 2011 | A1 |
20110071372 | Sloan et al. | Mar 2011 | A1 |
20110071464 | Palerm | Mar 2011 | A1 |
20110071465 | Wang et al. | Mar 2011 | A1 |
20110071765 | Yodfat et al. | Mar 2011 | A1 |
20110077481 | Say et al. | Mar 2011 | A1 |
20110077963 | Knudsen et al. | Mar 2011 | A1 |
20110082439 | Wenger et al. | Apr 2011 | A1 |
20110087165 | Amborn et al. | Apr 2011 | A1 |
20110092788 | Long et al. | Apr 2011 | A1 |
20110092894 | McGill et al. | Apr 2011 | A1 |
20110098548 | Budiman et al. | Apr 2011 | A1 |
20110098637 | Hill | Apr 2011 | A1 |
20110098638 | Chawla et al. | Apr 2011 | A1 |
20110098674 | Vicente et al. | Apr 2011 | A1 |
20110105955 | Yudovsky et al. | May 2011 | A1 |
20110106011 | Cinar et al. | May 2011 | A1 |
20110106050 | Yodfat et al. | May 2011 | A1 |
20110112504 | Causey et al. | May 2011 | A1 |
20110112505 | Starkweather et al. | May 2011 | A1 |
20110112506 | Starkweather et al. | May 2011 | A1 |
20110118578 | Timmerman | May 2011 | A1 |
20110118662 | Mhatre et al. | May 2011 | A1 |
20110118699 | Yodfat et al. | May 2011 | A1 |
20110124996 | Reinke et al. | May 2011 | A1 |
20110124999 | Reggiardo et al. | May 2011 | A1 |
20110125085 | McGill et al. | May 2011 | A1 |
20110125095 | Lebel et al. | May 2011 | A1 |
20110126188 | Bernstein et al. | May 2011 | A1 |
20110130716 | Estes et al. | Jun 2011 | A1 |
20110130746 | Budiman | Jun 2011 | A1 |
20110133946 | Kopp et al. | Jun 2011 | A1 |
20110137239 | Debelser et al. | Jun 2011 | A1 |
20110144586 | Michaud et al. | Jun 2011 | A1 |
20110144616 | Michaud et al. | Jun 2011 | A1 |
20110152770 | DiPerna et al. | Jun 2011 | A1 |
20110152824 | DiPerna et al. | Jun 2011 | A1 |
20110160654 | Hanson et al. | Jun 2011 | A1 |
20110160695 | Sigrist et al. | Jun 2011 | A1 |
20110166544 | Verhoef et al. | Jul 2011 | A1 |
20110166875 | Hayter et al. | Jul 2011 | A1 |
20110172744 | Davis et al. | Jul 2011 | A1 |
20110178461 | Chong et al. | Jul 2011 | A1 |
20110178462 | Moberg et al. | Jul 2011 | A1 |
20110178717 | Goodnow et al. | Jul 2011 | A1 |
20110184264 | Galasso et al. | Jul 2011 | A1 |
20110184342 | Pesach et al. | Jul 2011 | A1 |
20110190701 | Remde et al. | Aug 2011 | A1 |
20110193704 | Harper et al. | Aug 2011 | A1 |
20110196213 | Thukral et al. | Aug 2011 | A1 |
20110202040 | Remde et al. | Aug 2011 | A1 |
20110205065 | Strachan et al. | Aug 2011 | A1 |
20110208155 | Palerm et al. | Aug 2011 | A1 |
20110213225 | Bernstein et al. | Sep 2011 | A1 |
20110213306 | Hanson et al. | Sep 2011 | A1 |
20110256024 | Cole et al. | Oct 2011 | A1 |
20110257625 | Jasperson et al. | Oct 2011 | A1 |
20110257895 | Brauker et al. | Oct 2011 | A1 |
20110266999 | Yodfat et al. | Nov 2011 | A1 |
20120013625 | Blomquist et al. | Jan 2012 | A1 |
20120013802 | Blomquist et al. | Jan 2012 | A1 |
20120029433 | Michaud et al. | Feb 2012 | A1 |
20120029941 | Malave et al. | Feb 2012 | A1 |
20120030610 | DiPerna et al. | Feb 2012 | A1 |
20120041415 | Estes et al. | Feb 2012 | A1 |
20120053522 | Yodfat et al. | Mar 2012 | A1 |
20120059353 | Kovatchev et al. | Mar 2012 | A1 |
20120059673 | Cohen et al. | Mar 2012 | A1 |
20120095315 | Tenbarge et al. | Apr 2012 | A1 |
20120109100 | Estes et al. | May 2012 | A1 |
20120123230 | Brown et al. | May 2012 | A1 |
20120163481 | Ebner et al. | Jun 2012 | A1 |
20120185267 | Kamen et al. | Jul 2012 | A1 |
20120191061 | Yodfat et al. | Jul 2012 | A1 |
20120191063 | Brauker et al. | Jul 2012 | A1 |
20120226124 | Blomquist | Sep 2012 | A1 |
20120232484 | Blomquist | Sep 2012 | A1 |
20120232485 | Blomquist | Sep 2012 | A1 |
20120232520 | Sloan et al. | Sep 2012 | A1 |
20120232521 | Blomquist | Sep 2012 | A1 |
20120238852 | Brauker et al. | Sep 2012 | A1 |
20120238854 | Blomquist et al. | Sep 2012 | A1 |
20120239362 | Blomquist | Sep 2012 | A1 |
20120245524 | Estes et al. | Sep 2012 | A1 |
20120246106 | Atlas | Sep 2012 | A1 |
20120265722 | Blomquist | Oct 2012 | A1 |
20120277667 | Yodat et al. | Nov 2012 | A1 |
20120296269 | Blomquist | Nov 2012 | A1 |
20120330227 | Budiman et al. | Dec 2012 | A1 |
20130012917 | Miller et al. | Jan 2013 | A1 |
20130046281 | Javitt | Feb 2013 | A1 |
20130053816 | DiPerna et al. | Feb 2013 | A1 |
20130131630 | Blomquist | May 2013 | A1 |
20130324928 | Kruse | Dec 2013 | A1 |
20130331790 | Brown et al. | Dec 2013 | A1 |
20130345625 | Causey, III et al. | Dec 2013 | A1 |
20130345663 | Agrawal et al. | Dec 2013 | A1 |
20140005633 | Finan | Jan 2014 | A1 |
20140012511 | Mensinger et al. | Jan 2014 | A1 |
20140019396 | Carlsgaard et al. | Jan 2014 | A1 |
20140066890 | Sloan et al. | Mar 2014 | A1 |
20140074059 | Howell et al. | Mar 2014 | A1 |
20140137641 | Brown | May 2014 | A1 |
20140171772 | Blomquist | Jun 2014 | A1 |
20140180203 | Budiman | Jun 2014 | A1 |
20140273042 | Saint | Sep 2014 | A1 |
20140275419 | Ward et al. | Sep 2014 | A1 |
20140276419 | Rosinko et al. | Sep 2014 | A1 |
20140276420 | Rosinko | Sep 2014 | A1 |
20140276531 | Walsh | Sep 2014 | A1 |
20140276553 | Rosinko et al. | Sep 2014 | A1 |
20140276556 | Saint et al. | Sep 2014 | A1 |
20140276570 | Saint | Sep 2014 | A1 |
20140276574 | Saint | Sep 2014 | A1 |
20140350371 | Blomquist et al. | Nov 2014 | A1 |
20140378898 | Rosinko | Dec 2014 | A1 |
20150045770 | Debelser et al. | Feb 2015 | A1 |
20150073337 | Saint et al. | Mar 2015 | A1 |
20150165117 | Palerm | Jun 2015 | A1 |
20150182693 | Rosinko | Jul 2015 | A1 |
20150182695 | Rosinko | Jul 2015 | A1 |
20150217044 | Blomquist | Aug 2015 | A1 |
20150217051 | Mastrototaro | Aug 2015 | A1 |
20150314062 | Blomquist et al. | Nov 2015 | A1 |
20160030669 | Harris et al. | Feb 2016 | A1 |
20160082188 | Blomquist et al. | Mar 2016 | A1 |
20160199571 | Rosinko et al. | Jul 2016 | A1 |
20160228041 | Heller et al. | Aug 2016 | A1 |
20170000943 | Blomquist et al. | Jan 2017 | A1 |
20180092578 | Blomquist | Apr 2018 | A1 |
20180133397 | Estes | May 2018 | A1 |
20190328967 | Blomquist et al. | Oct 2019 | A1 |
20190350501 | Blomquist et al. | Nov 2019 | A1 |
20190365997 | Harris | Dec 2019 | A1 |
20190388015 | Blomquist | Dec 2019 | A1 |
20200101226 | Blomquist et al. | Apr 2020 | A1 |
20200114076 | Ulrich et al. | Apr 2020 | A1 |
20200261649 | Michaud et al. | Aug 2020 | A1 |
Number | Date | Country |
---|---|---|
399065 | Jul 1924 | DE |
4407005 | Mar 1995 | DE |
19819407 | Nov 1999 | DE |
10121317 | Nov 2002 | DE |
10352456 | Jul 2005 | DE |
1102194 | May 2001 | EP |
1571582 | Sep 2005 | EP |
2006034323 | Feb 2006 | JP |
WO-0045696 | Aug 2000 | WO |
WO-0074753 | Dec 2000 | WO |
WO-0152727 | Jul 2001 | WO |
WO-02062212 | Aug 2002 | WO |
WO-03082091 | Oct 2003 | WO |
WO-2005046559 | May 2005 | WO |
WO-2006061169 | Jun 2006 | WO |
WO-2006127841 | Nov 2006 | WO |
WO-2007000425 | Jan 2007 | WO |
WO-2007056592 | May 2007 | WO |
WO-2007065944 | Jun 2007 | WO |
WO-2007089537 | Aug 2007 | WO |
WO-2007149533 | Dec 2007 | WO |
WO-2008048556 | Apr 2008 | WO |
WO-2008048582 | Apr 2008 | WO |
WO-2008048583 | Apr 2008 | WO |
WO-2008048584 | Apr 2008 | WO |
WO-2008048585 | Apr 2008 | WO |
WO-2008048586 | Apr 2008 | WO |
WO-2008048587 | Apr 2008 | WO |
WO-2008091320 | Jul 2008 | WO |
WO-2008103175 | Aug 2008 | WO |
WO-2008112078 | Sep 2008 | WO |
WO-2008144693 | Nov 2008 | WO |
WO-2008144695 | Nov 2008 | WO |
WO-2008144697 | Nov 2008 | WO |
WO-2008144698 | Nov 2008 | WO |
WO-2008153689 | Dec 2008 | WO |
WO-2008153819 | Dec 2008 | WO |
WO-2009016636 | Feb 2009 | WO |
WO-2009032399 | Mar 2009 | WO |
WO-2009032400 | Mar 2009 | WO |
WO-2009035759 | Mar 2009 | WO |
WO-2009088983 | Jul 2009 | WO |
WO-2009089028 | Jul 2009 | WO |
WO-2009089029 | Jul 2009 | WO |
WO-2010111505 | Sep 2010 | WO |
WO-2011068648 | Jun 2011 | WO |
WO-2013016363 | Jan 2013 | WO |
WO-2013184896 | Dec 2013 | WO |
WO-2018085600 | May 2018 | WO |
Entry |
---|
Application and File History for U.S. Appl. No. 15/394,066, filed Dec. 29, 2016, inventor Rosinko. |
Bott, et al., “Impact of Smoking on the Metabolic Action of Subcutaneous Regular Insulin in Type 2 Diabetic Patients,” Horm. Metab. Res., vol. 37, 2005, pp. 445-449. |
Chase, et at., “The Use of Insulin Pumps With Meal Bolus Alarms in Children With Type 1 Diabetes to Improve Glycemic Control,” Diabetes Carem, vol. 29, No. 5, May 2006, pp. 1012-1015. |
“Compare Insulin Pump for Diabetes,” Printed from www.diabetesnet.com/diabetes-technology/insulin-pump-models.php, Jun. 18, 2009, 4 pages. |
Lehmann, et al., “Combining rule-based reasoning and mathematical modeling in diabetes care,” Artificial Intelligence in Medicine, vol. 6, 1994, pp. 137-160. |
Hildebrandt P, “Subcutaneous Absorption of Insulin in Insulin-Dependent Diavetic patients. Influence of Species Physico-Chemical properties of Insulin and Physiological factors,” Danish Medical Bulletin, Aug. 1991, 10 pages. |
Plougmann, et al., “DiasNet—a diabetes advisory system for communication and education via the internet,” International Journal of Medical Informatics, vol. 64, 2001, pp. 319-330. |
Puckett, et al., “A model for multiple subcutaneous insulin injections developed from individual diabetic patient data,” vol. 269, 1995, p. E1115-E1124. |
Smith Medical MD Inc., “Deltec Cozmo, Personalized Insulin Pump, Starting Guide,” http://web.archive.org/web/20041207133223/http://www.cozmore.com/Library/-upload/starting.sub.--guide.sub.--032004.pdf, XP002497833, Dec. 7, 2004, pp. 1-83. |
Stapel E., “Converting Between Decimals, Fractions, and Percents,” Purplemath, 2006, 9 pages, Available at http://www.purplemath.com/modules/percents2.htm, 2006. |
Trajanoski, et al., “Pharmacokinetic Model for the Absorption of Subcutaneously Injected Soluble Insulin and Monomeric Insulin Analogues,” Biomedizinische Technik, vol. 38, No. 9. Sep. 1, 1993, pp. 224-231. |
Wach, et al., “Numerical Approximation of Mathematical Model for Absorption of Subcutaneously Injected Insulin,” Med & Biol. Eng & comput., vol. 33, 1995, pp. 18-23. |
Walsh, et al., “Diabetes Technology—Concept 1: Super Bolus,” available at Diabetes Technology—Concept 1: Super Bolus available at http://www.diabetesnet.com/diabetes.sub.--technology/super.sub.--bolus.ph-p>, Sep. 17, 2007, 3 pages. |
Walsh J., et al., “Select & Test Your Correction Factor,” Pumping Insulin, Fourth Edition, Chapter 13, 2006, 10 Pages. |
Walsh J., et al., “Select & Test Your Basal Rates,” Pumping Insulin, Fourth Edition, Chapter 11, 2006, 30 pages. |
Walsh J., et al., “Select and Test Your Carb Factor,” Pumping Insulin, Fourth Edition, Chapter 12, 2006, 32 pages. |
Walsh J., et al., “Pumping Insulin: Everything you need for Success on a Smart insulin Pump,” Torrey Pines Press, San Diego, ISBN 1-884804-86-1, 2006, 3 pages. |
Wikipedia.com, “Wikipedia's definition for “basal rate”,” printed from wikipedia.com on Jun. 12, 2009, 1 page. |
Wilinska, et al., “Insulin Kinetics in Type-1 Diabetes: Continuous and Bolus Delivery of Rapid Acting Insulin,” IEEE Transactions on Biomedical Engineering, vol. 52, No. 1, Jan. 2005, pp. 3-12. |
Number | Date | Country | |
---|---|---|---|
20200179603 A1 | Jun 2020 | US |
Number | Date | Country | |
---|---|---|---|
62272255 | Dec 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15394066 | Dec 2016 | US |
Child | 16791129 | US |